Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 04-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,225 | -13,030 | -7,894 | -413 | -3,611 |
| Depreciation Amortization | 867 | 648 | 437 | 119 | 183 |
| Income taxes - deferred | N/A | N/A | N/A | -243 | N/A |
| Accounts receivable | N/A | N/A | N/A | 1,825 | N/A |
| Accounts payable and accrued liabilities | -617 | -197 | -1,026 | 285 | -358 |
| Other Working Capital | -2,820 | -1,327 | -2,200 | 1,401 | -2,455 |
| Other Operating Activity | 1,894 | 260 | 1,054 | -2,000 | 390 |
| Operating Cash Flow | $-16,901 | $-13,646 | $-9,629 | $974 | $-5,851 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -898 | -747 | -534 | -202 | -244 |
| Sale Of Investment | 23,550 | 14,070 | 9,479 | N/A | 5,530 |
| Purchase Sale Intangibles | -242 | -184 | -122 | N/A | -46 |
| Other Investing Activity | -313 | -255 | -193 | 0 | -46 |
| Investing Cash Flow | $22,339 | $13,068 | $8,752 | $-202 | $5,240 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -7,051 | N/A | N/A | -550 | N/A |
| Debt Repayment | -45 | -36 | -29 | -254 | -13 |
| Common Stock Issued | 249 | N/A | N/A | 32 | N/A |
| Financing Cash Flow | $-6,847 | $-36 | $-29 | $-772 | $-13 |
| Beginning Cash Position | 2,212 | 2,212 | 2,212 | 0 | 2,212 |
| End Cash Position | 803 | 1,598 | 1,306 | N/A | 1,588 |
| Net Cash Flow | $-1,409 | $-614 | $-906 | $0 | $-624 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,901 | -13,646 | -9,629 | 974 | -5,851 |
| Capital Expenditure | -898 | -747 | -534 | -202 | -244 |
| Free Cash Flow | -17,799 | -14,393 | -10,163 | 772 | -6,095 |